Discussing Recent Deals: GE Vernova, Honeywell, Chart-Flowserve

Introduction

When an interviewer asks you to discuss a deal you have been following, they are not testing whether you read the headline. They are testing whether you can analyze why the deal happened, how it was valued, what made it succeed or fail, and what it reveals about broader sector trends. A candidate who says "Honeywell is splitting into three companies" gets no credit. A candidate who explains that Elliott Management's SOTP analysis showed a 15-20% conglomerate discount, that the separation follows the GE template where separated entities' combined market cap exceeded the pre-split value by 4x, and that the execution involves standalone financial preparation, debt allocation, and transition services gets significant credit because the answer demonstrates genuine analytical understanding.

This article walks through the four most important 2024-2026 industrials transactions, organized not as a list of facts but as a framework for how to think about and discuss each one.

The facts: GE separated into GE Aerospace (jet engines, defense), GE Vernova (power, renewable energy), and GE HealthCare (medical imaging, diagnostics). GE HealthCare listed in January 2023; GE Vernova spun off on April 2, 2024. GE Aerospace retained the legacy NYSE ticker.

What makes it analytically interesting: The combined market value of the three separated entities is over 4x the value GE had before the breakup process began. GE Aerospace's stock rose from roughly $135 post-split to $348 by March 2026. This value creation through subtraction is the definitive empirical proof that industrial conglomerate discounts are real. Each entity attracted dedicated sector investors who applied pure-play multiples: GE Aerospace received premium A&D multiples, GE HealthCare received medtech multiples, and GE Vernova received energy infrastructure multiples. The blended conglomerate multiple that GE previously traded at was lower than any of the three pure-play multiples, which is the mechanical explanation for why the discount existed and why separation created value.

The facts: Honeywell announced in February 2025 a separation into Honeywell Aerospace, Honeywell Automation, and Advanced Materials (Solstice). The aerospace spin-off targets completion in H2 2026. Elliott Management's **$5+ billion** stake (disclosed November 2024) catalyzed the announcement. Wolfe Research projected a post-split SOTP of approximately $293 per share.

What makes it analytically interesting: The Honeywell separation is a live transaction that demonstrates the full activist campaign playbook: Elliott built the largest single-stock position in the firm's history, published a detailed SOTP showing 51-75% upside, and the board announced a separation within three months. The deal also illustrates the standalone margin adjustment debate that is central to conglomerate SOTP analysis: activists estimate higher standalone margins (arguing the conglomerate over-allocates corporate costs), while management estimates lower standalone margins (arguing shared services provide genuine value).

The facts: In June 2025, Chart Industries and Flowserve announced a $19 billion merger of equals (all-stock, 3.165 exchange ratio, 53.5% Chart / 46.5% Flowserve ownership, 50/50 board). In July 2025, Baker Hughes outbid the MOE with a $13.6 billion cash offer for Chart Industries, disrupting the planned combination.

The facts: Parker Hannifin acquired Filtration Group for $9.25 billion in November 2025. Filtration Group manufactures filtration products for life sciences, industrial processes, and indoor air quality applications.

What makes it analytically interesting: This deal exemplifies the strategic acquirer playbook in industrials, and it represents a different deal type than the separations and MOEs above, demonstrating breadth when discussed alongside those transactions. Parker's Win Strategy operating system will be applied to drive 100-300bp of margin improvement in the acquired business, which is the mechanism that allows Parker to pay a premium multiple and still generate attractive returns. The target fits Parker's long-term strategy of shifting toward higher-margin, less cyclical businesses with strong aftermarket replacement demand. The filtration products are mission-critical (contamination can destroy an entire production batch), creating the cost asymmetry that supports pricing power.

When discussing any industrials transaction, follow a consistent analytical framework:

Start with the "why." What was the strategic catalyst? For separations, it is usually the conglomerate discount and activist pressure. For acquisitions, it is usually capability acquisition (technology, geographic expansion, aftermarket growth) or scale consolidation (roll-up economics). Do not just state what happened; explain what drove the decision.

Address the valuation. How was the deal priced? For separations, reference the SOTP methodology. For acquisitions, reference the implied multiple and what quality tier it corresponds to. For cyclical targets, address whether the multiple was applied to trailing or mid-cycle EBITDA.

Discuss the execution complexity. Every significant deal has execution challenges that the banker must manage. For separations, discuss standalone financial preparation, debt allocation, and TSA structuring. For acquisitions, discuss regulatory requirements (HSR, CFIUS for defense-related targets), financing structure, and integration planning. For MOEs, discuss the exchange ratio negotiation and governance design. Demonstrating awareness of execution challenges shows you understand deals as multi-dimensional advisory engagements, not just headline numbers.

Offer your own view. Interviewers want to see that you can form and defend an opinion, not just recite facts. "I think the GE breakup was clearly value-creating because the combined market cap of the three entities is 4x the pre-breakup level" is stronger than "the GE breakup happened in 2024." Even stronger: "I think the Honeywell separation will create less dramatic value than GE's because the conglomerate discount at Honeywell was smaller and the Solventum precedent shows that not all spinoffs immediately re-rate to pure-play multiples."